Catherine Hastie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Catherine Hastie has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Farshid
Australian National University, Canberra, ACT, Australia; National Capital Private Hospital, Canberra, ACT, Australia
1 shared publication Arash Akbarzad‐Yousefi
National Blood Service Newcastle‐upon‐Tyne Newcastle upon Tyne UK
1 shared publication- Arthi Anand
Histocompatibility and Immunogenetics Laboratory, Northwest London Pathology NHS Trust, Hammersmith Hospital, London, United Kingdom
1 shared publication B. Nkoane-Kelaeng
The Canberra Hospital, Garran, Australia
1 shared publication- C. McCallum
The Canberra Hospital, Garran, Australia
1 shared publication - Carla Rosser
National Blood Service Tooting London UK
1 shared publication
Latest Publications
- 2 November 2023
- Published by Wiley in International Journal of Immunogenetics
- Vol. 50 (S2) , 3-63
BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantation
Solid organ transplantation represents the best (and in many cases only) treatment option for patients with end‐stage organ failure. The effectiveness and functioning life of these transplants has improved each decade due to surgical and clinical advances, and accurate histocompatibility assessment. Patient exposure to alloantigen from another individual is a common occurrence and takes place through pregnancies, blood transfusions or previous transplantation. Such exposure to alloantigen's can lead to the formation of circulating alloreactive antibodies which can be deleterious to solid organ transplant outcome. The purpose of these guidelines is to update to the previous BSHI/BTS guidelines 2016 on the relevance, assessment, and management of alloantibodies within solid organ transplantation.
- 2 November 2023
- Published by Wiley in International Journal of Immunogenetics
- Vol. 50 (S2) , 3-63
BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantation
Solid organ transplantation represents the best (and in many cases only) treatment option for patients with end‐stage organ failure. The effectiveness and functioning life of these transplants has improved each decade due to surgical and clinical advances, and accurate histocompatibility assessment. Patient exposure to alloantigen from another individual is a common occurrence and takes place through pregnancies, blood transfusions or previous transplantation. Such exposure to alloantigen's can lead to the formation of circulating alloreactive antibodies which can be deleterious to solid organ transplant outcome. The purpose of these guidelines is to update to the previous BSHI/BTS guidelines 2016 on the relevance, assessment, and management of alloantibodies within solid organ transplantation.
- Open Access
- 24 June 2019
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 28, S222
Nurse-Led Protocol-Based Atrial Fibrillation Clinic Associated with High Quality Care for Patients
- 24 June 2019
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 28, S222
Open AccessNurse-Led Protocol-Based Atrial Fibrillation Clinic Associated with High Quality Care for Patients